Exclusivity of Molecular Targets. Molecular Targets for which Pfizer has initiated HTS shall be exclusive to Pfizer and shall not be conveyed to a third party in any manner by Rigel.
Appears in 5 contracts
Sources: Collaborative Research and License Agreement, Collaborative Research and License Agreement (Rigel Pharmaceuticals Inc), Collaborative Research and License Agreement (Rigel Pharmaceuticals Inc)